< Back to previous page

Publication

Ciltacabtagene autoleucel for patients with triple-class exposed multiple myeloma

Journal Contribution - Letter to Editor

Subtitle:adjusted comparison of CARTITUDE-1 patient outcomes versus real-world clinical practice

Journal: HemaSphere

ISSN: 2572-9241

Volume: 6

Pages: 1 - 4

Publication year:2022

Keywords:L1 Letter to the editor

WoS Id: 000893221200009
DOI: https://doi.org/10.1097/hs9.0000000000000813
Handle: https://hdl.handle.net/10067/1922410151162165141

Accessibility:Open

See also: Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice